29 Long-term outcomes in the surgical management of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy
Hypertrophic Cardiomyopathy is the most common genetically inherited cardiac disease affecting 1 in 500 of the population. Dynamic Left Ventricular Outflow Tract Obstruction (LVOTO) caused by systolic anterior motion of the mitral valve is present in up to two thirds of patients. Surgical interventi...
Gespeichert in:
Veröffentlicht in: | Heart (British Cardiac Society) 2016-10, Vol.102 (Suppl 9), p.A16 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | Suppl 9 |
container_start_page | A16 |
container_title | Heart (British Cardiac Society) |
container_volume | 102 |
creator | Collis, R Watkinson, O O’Mahony, C Guttmann, O Elliott, P |
description | Hypertrophic Cardiomyopathy is the most common genetically inherited cardiac disease affecting 1 in 500 of the population. Dynamic Left Ventricular Outflow Tract Obstruction (LVOTO) caused by systolic anterior motion of the mitral valve is present in up to two thirds of patients. Surgical intervention can alleviate LVOTO and improve symptoms but the risks and long-term outcomes of different surgical strategies are unknown.MethodsSurvival and clinical outcomes were assessed at 1, 5 and 10 years post operatively in 362 patients with HCM undergoing surgical intervention for LVOTO at a specialist cardiomyopathy centre. The primary survival endpoint was all cause mortality.ResultsGroup A (n = 286) underwent septal myectomy; Group B (n = 32) underwent septal myectomy and MV repair; Group C (n = 26) underwent myectomy and MV replacement and Group D (n = 17) underwent MV replacement without myectomy. There were 93 concomitant procedures including CABG, AVR, MAZE procedure and left atrial appendage closure across groups. Mean follow up was 6.2 years and longest follow up was 46.6 years. NYHA functional class improved from 2.49 to 1.48 postoperatively (p < 0.05). The mean resting LVOT gradient improved from 72 mmHg to 13.6 mmHg at 1 year post procedure; 14.4% of patients were operated on because of latent obstruction. There were 16 repeat surgeries including 9 redo myectomies, 6 MV Replacements and 1 MV Repair with a mean time to reintervention of 5.3 years. 28 patients met the primary endpoint of all-cause mortality at a mean of 9.6 years. There were 4 procedural related mortalities and 24 mortalities on late follow up greater than 30 days post procedure. Survival analysis was estimated using Kaplan-Meier curves and log-rank testing. Estimated survival rates post-operatively at 1, 5 and 10 years respectively were 98.9%, 97.5%, 93.7% in group A; 97%, 97%, 32.3% in group B 96.2%, 90.5%, 90.5% in group C; and 93.3%, 80%, 80% in the group D (p < 0.05).ConclusionDifferent surgical techniques are adopted for the management of LVOTO. Septal myectomy in particular is shown to have good long term outcomes with low rates of reintervention. |
doi_str_mv | 10.1136/heartjnl-2016-310523.29 |
format | Article |
fullrecord | <record><control><sourceid>proquest_bmj_p</sourceid><recordid>TN_cdi_proquest_journals_1824986851</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4200938521</sourcerecordid><originalsourceid>FETCH-LOGICAL-b711-991bcd458592ad9847a41e1d0deba5a1668aa3ff0ece33d5bdd535f5459886a13</originalsourceid><addsrcrecordid>eNo1kMtKxDAUhoMoOI4-gwHXHXNpOslSBm8w4GYW7sJpkk5b2qamqdKVbnxRn8Qpo6tz4Tv_gQ-ha0pWlPLstnQQYt01CSM0SzglgvEVUydoQdNMztvX00PPhUgywtfn6GIYakJIqmS2QJ9M_Xx9b323T6ILLfZjNL51A646HEuHhzHsKwMNbqGDvWtdF7EvcOOKiN8PQ6jM2ECY74rGf-AYwByIfIhhNLHy3RxUTr0LMfi-rAw2EGzl28n3EMvpEp0V0Azu6q8u0e7hfrd5SrYvj8-bu22SrylNlKK5samQQjGwSqZrSKmjlliXgwCaZRKAFwVxxnFuRW6t4KIQqVBSZkD5Et0cY_vg30Y3RF37MXSHj5pKNquQYqbYkcrbWvehaiFMmhI9e9b_nvXsWR89a6b4L0Owd68</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1824986851</pqid></control><display><type>article</type><title>29 Long-term outcomes in the surgical management of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy</title><source>BMJ Journals - NESLi2</source><source>PubMed Central</source><creator>Collis, R ; Watkinson, O ; O’Mahony, C ; Guttmann, O ; Elliott, P</creator><creatorcontrib>Collis, R ; Watkinson, O ; O’Mahony, C ; Guttmann, O ; Elliott, P</creatorcontrib><description>Hypertrophic Cardiomyopathy is the most common genetically inherited cardiac disease affecting 1 in 500 of the population. Dynamic Left Ventricular Outflow Tract Obstruction (LVOTO) caused by systolic anterior motion of the mitral valve is present in up to two thirds of patients. Surgical intervention can alleviate LVOTO and improve symptoms but the risks and long-term outcomes of different surgical strategies are unknown.MethodsSurvival and clinical outcomes were assessed at 1, 5 and 10 years post operatively in 362 patients with HCM undergoing surgical intervention for LVOTO at a specialist cardiomyopathy centre. The primary survival endpoint was all cause mortality.ResultsGroup A (n = 286) underwent septal myectomy; Group B (n = 32) underwent septal myectomy and MV repair; Group C (n = 26) underwent myectomy and MV replacement and Group D (n = 17) underwent MV replacement without myectomy. There were 93 concomitant procedures including CABG, AVR, MAZE procedure and left atrial appendage closure across groups. Mean follow up was 6.2 years and longest follow up was 46.6 years. NYHA functional class improved from 2.49 to 1.48 postoperatively (p < 0.05). The mean resting LVOT gradient improved from 72 mmHg to 13.6 mmHg at 1 year post procedure; 14.4% of patients were operated on because of latent obstruction. There were 16 repeat surgeries including 9 redo myectomies, 6 MV Replacements and 1 MV Repair with a mean time to reintervention of 5.3 years. 28 patients met the primary endpoint of all-cause mortality at a mean of 9.6 years. There were 4 procedural related mortalities and 24 mortalities on late follow up greater than 30 days post procedure. Survival analysis was estimated using Kaplan-Meier curves and log-rank testing. Estimated survival rates post-operatively at 1, 5 and 10 years respectively were 98.9%, 97.5%, 93.7% in group A; 97%, 97%, 32.3% in group B 96.2%, 90.5%, 90.5% in group C; and 93.3%, 80%, 80% in the group D (p < 0.05).ConclusionDifferent surgical techniques are adopted for the management of LVOTO. Septal myectomy in particular is shown to have good long term outcomes with low rates of reintervention.</description><identifier>ISSN: 1355-6037</identifier><identifier>EISSN: 1468-201X</identifier><identifier>DOI: 10.1136/heartjnl-2016-310523.29</identifier><language>eng</language><publisher>London: BMJ Publishing Group LTD</publisher><ispartof>Heart (British Cardiac Society), 2016-10, Vol.102 (Suppl 9), p.A16</ispartof><rights>2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>Copyright: 2016 (c) 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://heart.bmj.com/content/102/Suppl_9/A16.1.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttps://heart.bmj.com/content/102/Suppl_9/A16.1.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,780,784,23571,27924,27925,77600,77631</link.rule.ids></links><search><creatorcontrib>Collis, R</creatorcontrib><creatorcontrib>Watkinson, O</creatorcontrib><creatorcontrib>O’Mahony, C</creatorcontrib><creatorcontrib>Guttmann, O</creatorcontrib><creatorcontrib>Elliott, P</creatorcontrib><title>29 Long-term outcomes in the surgical management of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy</title><title>Heart (British Cardiac Society)</title><description>Hypertrophic Cardiomyopathy is the most common genetically inherited cardiac disease affecting 1 in 500 of the population. Dynamic Left Ventricular Outflow Tract Obstruction (LVOTO) caused by systolic anterior motion of the mitral valve is present in up to two thirds of patients. Surgical intervention can alleviate LVOTO and improve symptoms but the risks and long-term outcomes of different surgical strategies are unknown.MethodsSurvival and clinical outcomes were assessed at 1, 5 and 10 years post operatively in 362 patients with HCM undergoing surgical intervention for LVOTO at a specialist cardiomyopathy centre. The primary survival endpoint was all cause mortality.ResultsGroup A (n = 286) underwent septal myectomy; Group B (n = 32) underwent septal myectomy and MV repair; Group C (n = 26) underwent myectomy and MV replacement and Group D (n = 17) underwent MV replacement without myectomy. There were 93 concomitant procedures including CABG, AVR, MAZE procedure and left atrial appendage closure across groups. Mean follow up was 6.2 years and longest follow up was 46.6 years. NYHA functional class improved from 2.49 to 1.48 postoperatively (p < 0.05). The mean resting LVOT gradient improved from 72 mmHg to 13.6 mmHg at 1 year post procedure; 14.4% of patients were operated on because of latent obstruction. There were 16 repeat surgeries including 9 redo myectomies, 6 MV Replacements and 1 MV Repair with a mean time to reintervention of 5.3 years. 28 patients met the primary endpoint of all-cause mortality at a mean of 9.6 years. There were 4 procedural related mortalities and 24 mortalities on late follow up greater than 30 days post procedure. Survival analysis was estimated using Kaplan-Meier curves and log-rank testing. Estimated survival rates post-operatively at 1, 5 and 10 years respectively were 98.9%, 97.5%, 93.7% in group A; 97%, 97%, 32.3% in group B 96.2%, 90.5%, 90.5% in group C; and 93.3%, 80%, 80% in the group D (p < 0.05).ConclusionDifferent surgical techniques are adopted for the management of LVOTO. Septal myectomy in particular is shown to have good long term outcomes with low rates of reintervention.</description><issn>1355-6037</issn><issn>1468-201X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNo1kMtKxDAUhoMoOI4-gwHXHXNpOslSBm8w4GYW7sJpkk5b2qamqdKVbnxRn8Qpo6tz4Tv_gQ-ha0pWlPLstnQQYt01CSM0SzglgvEVUydoQdNMztvX00PPhUgywtfn6GIYakJIqmS2QJ9M_Xx9b323T6ILLfZjNL51A646HEuHhzHsKwMNbqGDvWtdF7EvcOOKiN8PQ6jM2ECY74rGf-AYwByIfIhhNLHy3RxUTr0LMfi-rAw2EGzl28n3EMvpEp0V0Azu6q8u0e7hfrd5SrYvj8-bu22SrylNlKK5samQQjGwSqZrSKmjlliXgwCaZRKAFwVxxnFuRW6t4KIQqVBSZkD5Et0cY_vg30Y3RF37MXSHj5pKNquQYqbYkcrbWvehaiFMmhI9e9b_nvXsWR89a6b4L0Owd68</recordid><startdate>201610</startdate><enddate>201610</enddate><creator>Collis, R</creator><creator>Watkinson, O</creator><creator>O’Mahony, C</creator><creator>Guttmann, O</creator><creator>Elliott, P</creator><general>BMJ Publishing Group LTD</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>201610</creationdate><title>29 Long-term outcomes in the surgical management of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy</title><author>Collis, R ; Watkinson, O ; O’Mahony, C ; Guttmann, O ; Elliott, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b711-991bcd458592ad9847a41e1d0deba5a1668aa3ff0ece33d5bdd535f5459886a13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Collis, R</creatorcontrib><creatorcontrib>Watkinson, O</creatorcontrib><creatorcontrib>O’Mahony, C</creatorcontrib><creatorcontrib>Guttmann, O</creatorcontrib><creatorcontrib>Elliott, P</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Heart (British Cardiac Society)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Collis, R</au><au>Watkinson, O</au><au>O’Mahony, C</au><au>Guttmann, O</au><au>Elliott, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>29 Long-term outcomes in the surgical management of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy</atitle><jtitle>Heart (British Cardiac Society)</jtitle><date>2016-10</date><risdate>2016</risdate><volume>102</volume><issue>Suppl 9</issue><spage>A16</spage><pages>A16-</pages><issn>1355-6037</issn><eissn>1468-201X</eissn><abstract>Hypertrophic Cardiomyopathy is the most common genetically inherited cardiac disease affecting 1 in 500 of the population. Dynamic Left Ventricular Outflow Tract Obstruction (LVOTO) caused by systolic anterior motion of the mitral valve is present in up to two thirds of patients. Surgical intervention can alleviate LVOTO and improve symptoms but the risks and long-term outcomes of different surgical strategies are unknown.MethodsSurvival and clinical outcomes were assessed at 1, 5 and 10 years post operatively in 362 patients with HCM undergoing surgical intervention for LVOTO at a specialist cardiomyopathy centre. The primary survival endpoint was all cause mortality.ResultsGroup A (n = 286) underwent septal myectomy; Group B (n = 32) underwent septal myectomy and MV repair; Group C (n = 26) underwent myectomy and MV replacement and Group D (n = 17) underwent MV replacement without myectomy. There were 93 concomitant procedures including CABG, AVR, MAZE procedure and left atrial appendage closure across groups. Mean follow up was 6.2 years and longest follow up was 46.6 years. NYHA functional class improved from 2.49 to 1.48 postoperatively (p < 0.05). The mean resting LVOT gradient improved from 72 mmHg to 13.6 mmHg at 1 year post procedure; 14.4% of patients were operated on because of latent obstruction. There were 16 repeat surgeries including 9 redo myectomies, 6 MV Replacements and 1 MV Repair with a mean time to reintervention of 5.3 years. 28 patients met the primary endpoint of all-cause mortality at a mean of 9.6 years. There were 4 procedural related mortalities and 24 mortalities on late follow up greater than 30 days post procedure. Survival analysis was estimated using Kaplan-Meier curves and log-rank testing. Estimated survival rates post-operatively at 1, 5 and 10 years respectively were 98.9%, 97.5%, 93.7% in group A; 97%, 97%, 32.3% in group B 96.2%, 90.5%, 90.5% in group C; and 93.3%, 80%, 80% in the group D (p < 0.05).ConclusionDifferent surgical techniques are adopted for the management of LVOTO. Septal myectomy in particular is shown to have good long term outcomes with low rates of reintervention.</abstract><cop>London</cop><pub>BMJ Publishing Group LTD</pub><doi>10.1136/heartjnl-2016-310523.29</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1355-6037 |
ispartof | Heart (British Cardiac Society), 2016-10, Vol.102 (Suppl 9), p.A16 |
issn | 1355-6037 1468-201X |
language | eng |
recordid | cdi_proquest_journals_1824986851 |
source | BMJ Journals - NESLi2; PubMed Central |
title | 29 Long-term outcomes in the surgical management of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T22%3A56%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_bmj_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=29%E2%80%85Long-term%20outcomes%20in%20the%20surgical%20management%20of%20left%20ventricular%20outflow%20tract%20obstruction%20in%20hypertrophic%20cardiomyopathy&rft.jtitle=Heart%20(British%20Cardiac%20Society)&rft.au=Collis,%20R&rft.date=2016-10&rft.volume=102&rft.issue=Suppl%209&rft.spage=A16&rft.pages=A16-&rft.issn=1355-6037&rft.eissn=1468-201X&rft_id=info:doi/10.1136/heartjnl-2016-310523.29&rft_dat=%3Cproquest_bmj_p%3E4200938521%3C/proquest_bmj_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1824986851&rft_id=info:pmid/&rfr_iscdi=true |